Back

Speech-in-Noise Difficulties in Aminoglycoside Ototoxicity Reflects Combined Afferent and Efferent Dysfunction

Motlagh Zadeh, L.; Izhiman, D.; Blankenship, C. M.; Moore, D. R.; Martin, D. K.; Garinis, A.; Feeney, P.; Hunter, L. R.

2026-03-26 otolaryngology
10.64898/2026.03.23.26348719 medRxiv
Show abstract

Objectives: Patients with Cystic fibrosis (CF) often receive aminoglycosides (AGs) to manage recurrent pulmonary infections, placing them at risk for ototoxicity. Chronic AG use can lead to complex cochlear damage affecting inner and outer hair cells, the stria vascularis, and spiral ganglion neurons. The greatest damage is typically in the basal cochlear region, which encodes high-frequency hearing, with additional involvement of more apical regions. While extended-high-frequency (EHF) hearing loss (EHFHL; 9-16 kHz) is often the earliest sign of AG ototoxicity, speech in noise (SiN) effects are rarely studied. Our overall hypothesis is that SiN perception difficulties in individuals with CF, treated with AGs, are related to combined cochlear and neural damage, primarily in the EHF range but also in the standard frequency (SF; 0.25-8 kHz) range. Three mechanisms that contribute to SiN perception were evaluated in children and young adults: 1) a primary effect of reduced EHF sensitivity, measured by pure-tone audiometry (PTA) and transient-evoked otoacoustic emissions (TEOAEs); 2) a secondary effect of subclinical damage in the SF range, measured by PTA and TEOAEs; and 3) additional neural effects, measured by middle ear muscle reflex (MEMR) threshold (afferent) and growth functions (efferent).Design:A total of 185 participants were enrolled; 101 individuals with CF treated with intravenous AGs and 84 age and sex-matched Controls without hearing concerns or CF. Assessments included EHF and SF PTA; the Bamford-Kowal-Bench (BKB)-SIN test for SiN perception; double-evoked TEOAEs with chirp stimuli from 0.71 to 14.7 kHz; and ipsilateral and contralateral wideband MEMR thresholds and growth functions using broadband stimuli. Results: Reduced sensitivity at EHFs (PTA, TEOAEs) was not associated with impaired SiN perception in the CF group. SF hearing, regardless of EHF status, was the primary predictor of SiN performance in the CF group. Increased MEMR growth was also significantly associated with poorer SiN in the CF group. Conclusions: In CF, impaired SiN perception was primarily predicted by SF hearing impairment, with additional involvement of the efferent auditory pathway through increased MEMR growth. These results build on prior evidence for efferent neural effects due to ototoxic exposures, supporting both sensory (afferent) and neural (efferent) mechanisms that contribute to listening difficulties in CF. Thus, preventive and intervention strategies should consider these combined mechanisms in people with AG ototoxicity to address their SiN problems.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 12%
14.7%
2
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.1%
12.6%
3
Ear & Hearing
15 papers in training set
Top 0.1%
10.3%
4
Hearing Research
49 papers in training set
Top 0.1%
6.5%
5
Scientific Reports
3102 papers in training set
Top 28%
4.3%
6
The Journal of Neuroscience
928 papers in training set
Top 3%
3.7%
50% of probability mass above
7
Journal of the Association for Research in Otolaryngology
11 papers in training set
Top 0.1%
3.7%
8
ERJ Open Research
44 papers in training set
Top 0.3%
2.8%
9
Trends in Hearing
12 papers in training set
Top 0.1%
2.7%
10
Journal of Clinical Medicine
91 papers in training set
Top 2%
2.7%
11
Frontiers in Immunology
586 papers in training set
Top 3%
2.5%
12
Frontiers in Neurology
91 papers in training set
Top 2%
2.4%
13
JCI Insight
241 papers in training set
Top 2%
2.4%
14
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
15
Vaccine
189 papers in training set
Top 1%
1.7%
16
Cells
232 papers in training set
Top 3%
1.5%
17
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
1.4%
18
npj Digital Medicine
97 papers in training set
Top 3%
1.1%
19
iScience
1063 papers in training set
Top 26%
0.9%
20
Clinical and Translational Medicine
30 papers in training set
Top 0.8%
0.8%
21
The Journal of the Acoustical Society of America
33 papers in training set
Top 0.2%
0.8%
22
eLife
5422 papers in training set
Top 55%
0.8%
23
Pharmaceuticals
33 papers in training set
Top 2%
0.8%
24
Nature Communications
4913 papers in training set
Top 62%
0.8%
25
The Journal of Infectious Diseases
182 papers in training set
Top 5%
0.8%
26
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
0.8%
27
ACS Chemical Neuroscience
60 papers in training set
Top 3%
0.7%
28
Journal of Speech, Language, and Hearing Research
10 papers in training set
Top 0.1%
0.7%
29
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 1%
0.5%
30
Chemical Senses
30 papers in training set
Top 0.2%
0.5%